1Speidl W S, Exner M, Amighi J et al. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis [ J]. Eur Heart J, 2005 ;26(21 ) :2294-2299.
2Chan R K, Ibrahim S I, Takahashi K et al. the differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion [J]. J Immunol, 2006; 177 ( 11 ) : 8080-8085.
3Vasil K E, Magro C M. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda[J] .J Am Acad Dermatol,2007;56(1):96-104.
4Biro E, Nieuwland R, Tak P P et al. Activated complement components and complement activatomolectdes on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals [J] .Ann Rheum Dis,2007;66(8): 1085-1092.
5Woodruff T M, Pollitt S, Proctor L Met al. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease[J] .J Pharmacol Exp Ther,2005;314(2) :811-817.
6Trouw L A,Seelen M A,Duijs J M et al.Activation of the lecfin pathway in murine lupus nephritis[J]. Mol Immunol,2005 ;42(6):731-734.
7Justin C Mason, Helen Yarwood, Katharine Sugars et al. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition[ J]. Blood, 1999;94(5) : 1673-1682.
8Saifur R A, Elaine A L, Riedo Ohta et al. Decay-accelerating factor induction by tumoumecrosis factor-α, through a phosphatidylinositol-3 kinase and protein kinase C-dependentpathway, protects murine vascular endothelial cells against complement deposition [ J ]. Immunology, 2003 ; 110 : 258- 268.
9Spiller O Criado-Garciaa, S Rodriatguez De Coardoba, Morgan B P. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma ceils from complement attack [ J ]. Clin Exp I mmunol, 2000; 121: 234-241.
10Hyc A,Osiecka-lwan A,Strzelczyk Pet ol. Effect of IL-lbeta,TNF-alpha and IL-4 on complement regulatory protein mRNA expression in human articular chondrocytes[ J]. Int J Mol Med, 2003; 11 ( 1 ) : 91-94.
8Biownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414(5):813-820.
9Haskard DO, Boyle JJ, Mason IC. The role of complement in atherosclerosis. Curr Opin Lipidol. 2008 Oct; 19(5):478-82.
10Ruth D. Lewis, Christopher L. Jackson, B. Paul Morgan, et al.The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice I Mol Immunol. 2010 February; 47(5): 1098-1105.
